Seffalair Spiromax Den Europæiske Union - dansk - EMA (European Medicines Agency)

seffalair spiromax

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - medicin for obstruktiv sygdomme, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Flixonase 1 mg/ml næsedråber, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

flixonase 1 mg/ml næsedråber, suspension

haleon denmark aps - fluticasonpropionat - næsedråber, suspension - 1 mg/ml

Otrason 50 mikrogram/dosis næsespray, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

otrason 50 mikrogram/dosis næsespray, suspension

haleon denmark aps - fluticasonpropionat - næsespray, suspension - 50 mikrogram/dosis

Flixotide 100 mikrogram/dosis inhalationspulver Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

flixotide 100 mikrogram/dosis inhalationspulver

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationspulver - 100 mikrogram/dosis

Flixotide 250 mikrogram/dosis inhalationspulver Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

flixotide 250 mikrogram/dosis inhalationspulver

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationspulver - 250 mikrogram/dosis

Flixotide 500 mikrogram/dosis inhalationspulver Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

flixotide 500 mikrogram/dosis inhalationspulver

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationspulver - 500 mikrogram/dosis

Flixotide 50 mikrogram/dosis inhalationspulver Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

flixotide 50 mikrogram/dosis inhalationspulver

glaxosmithkline pharma a/s - fluticasonpropionat - inhalationspulver - 50 mikrogram/dosis